CLEARSIDE BIOMEDICAL INC (CLSD)

US1850631045 - Common Stock

1.34  +0.08 (+6.35%)

After market: 1.31 -0.03 (-2.24%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
8.23M1.33M29.58M7.89M2.17M
Cost Of Goods
355.00K200.00KN/AN/AN/A
Gross Profit
7.87M1.12MN/AN/AN/A
Operating Expenses
32.71M31.41M30.20M25.83M32.48M
Research and Development
20.85M19.63M18.54M15.07M15.66M
Selling, General, and Administrative Expenses
11.87M11.77M11.67M10.76M16.82M
Operating Income
-24.84M-30.28M-620.00K-17.94M-30.30M
Interest Income/Expense
N/AN/AN/AN/AN/A
Other Income/Expense
-9.36M-3.34M0.00-280.00K-470.00K
Non Recurring Items
1.72M670.00K1.00MN/AN/A
Income Before Taxes
-32.48M-32.95M380.00K-18.21M-30.77M
Income Tax
N/A0.00N/AN/AN/A
Net Income
-32.48M-32.95M380.00K-18.21M-30.77M
EBITDA
-24.78M-30.13M-440.00K-17.76M-30.09M
 
Per Share Data
EPS Diluted Total Ops
-0.53-0.550.01-0.39-0.81
Non GAAP EPS
-0.53-0.55-0.01-0.39-0.91
 
Statistics
Gross Profit Margin
95.68%84.21%N/AN/AN/A
Profit Margin
-394.91%-2477.44%1.28%-230.80%-1417.97%
Operating Profit Margin
-302.02%-2276.69%-2.10%-227.38%-1396.31%

All data in USD

Charts